FDA Inspection 1248367 — LifeShare Blood Center
The FDA completed an inspection of LifeShare Blood Center on Jul 12, 2024 in Lafayette, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 12, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lafayette, LA (United States)